Compound ID | 743
FMA 0713
Class: Macrolide
| Agent Type: | Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against erythromycin-resistant and -susceptible Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus |
| Institute where first reported: | Taisho Pharmaceuticals |
| Year first mentioned: | 1999 |
| Development status: | Experimental |
| External links: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.